Prevencio is a developer of multi-proteomic biomarkers designed to revolutionize blood tests for cardiovascular disease.

Health Care

Health Diagnostics

Prevencio

Prevencio's headquarters in Kirkland, WA, United States

Rhonda F. Rhyne

Katherine Kass

Craig A. Magaret

Missy Martin-Kemp

Michele McCarthy

Celine Peters

James L. Januzzi

Mark Houston

John F. Cramer III

The Leadership Team at Prevencio is responsible for setting the strategic direction of the company, guiding the development and commercialization of innovative multi-proteomic biomarkers for cardiovascular disease. Comprising key executives with diverse expertise, the team collaborates to drive operational efficiency, ensure financial sustainability, and foster partnerships that enhance the company's impact in the healthcare sector.

Leadership Team

The Chief Officers Team at Prevencio oversees strategic planning and execution across various functions, ensuring the development and commercialization of innovative multi-proteomic biomarkers. This includes scientific leadership, operational management, financial oversight, advanced data analytics, and market strategy formulation to revolutionize cardiovascular disease diagnostics.

Chief Officers Team

The Clinical and Scientific Team at Prevencio is responsible for developing and validating multi-proteomic biomarkers to enhance the accuracy and effectiveness of blood tests for cardiovascular disease. They collaborate on clinical trials, provide scientific insights, and support market development to ensure the successful implementation of Prevencio's diagnostic technologies.

��

Prevencio

Org chart

Board & advisors

Teams

Leadership Team

Chief Officers Team

Clinical and Scientific Team

Offices

��������

Prevencio

Org chart

Board & advisors

Teams

Leadership Team

Chief Officers Team

Clinical and Scientific Team

Offices

Related companies

��